RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients.
Clinical trial NCT04963413 · TERMINATED
Trial details
- NCT number
- NCT04963413
- Sponsor
- University of Florida
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-13
- Primary completion
- 2023-09-28
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.